Organic anion-transporting polypeptides.

Organic anion-transporting polypeptides or OATPs are central transporters in the disposition of drugs and other xenobiotics. In addition, they mediate transport of a wide variety of endogenous substrates. The critical role of OATPs in drug disposition has spurred research both in academia and in the pharmaceutical industry. Translational aspects with clinical questions are the focus in academia, while the pharmaceutical industry tries to define and understand the role these transporters play in pharmacotherapy. The present overview summarizes our knowledge on the interaction of food constituents with OATPs and on the OATP transport mechanisms. Further, it gives an update on the available information on the structure-function relationship of the OATPs and, finally, covers the transcriptional and posttranscriptional regulation of OATPs.

[1]  Fabian Müller,et al.  Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects , 2013, Pharmacological Reviews.

[2]  T. Abe,et al.  Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1. , 2010, Drug Metabolism and Pharmacokinetics.

[3]  Michal Heger,et al.  The emerging role of transport systems in liver function tests. , 2012, European journal of pharmacology.

[4]  Ralf-Torsten Pohl,et al.  Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning , 2012, Current pharmaceutical biotechnology.

[5]  S. Ishikawa,et al.  Functional Characterization of Rat Brain-specific Organic Anion Transporter (Oatp14) at the Blood-Brain Barrier , 2003, Journal of Biological Chemistry.

[6]  T. Nakanishi,et al.  Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. , 2011, Drug metabolism and pharmacokinetics.

[7]  P. Ferenci,et al.  Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. , 2008, Gastroenterology.

[8]  G. Folkers,et al.  Identification of steroid sulfate transport processes in the human mammary gland. , 2003, The Journal of clinical endocrinology and metabolism.

[9]  H. Daniel,et al.  Demonstration and modification of intervillous pH profiles in rat small intestine in vitro. , 1989, The American journal of physiology.

[10]  J. González‐Gallego,et al.  Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. , 2003, The Biochemical journal.

[11]  P. Meier,et al.  Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. , 1996, The Journal of pharmacology and experimental therapeutics.

[12]  Ulf Norinder,et al.  Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions , 2012, Journal of medicinal chemistry.

[13]  Nan Li,et al.  Identification of Amino Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain 2 of Organic Anion Transporting Polypeptide 1B1 , 2012, PloS one.

[14]  Y. Sawada,et al.  EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2006, Drug Metabolism and Disposition.

[15]  Sriram Subramaniam,et al.  Cryo‐electron microscopy – a primer for the non‐microscopist , 2013, The FEBS journal.

[16]  H. Hussain,et al.  Primovist, Eovist: what to expect? , 2012, Journal of hepatology.

[17]  Y. Kato,et al.  Pdz Adaptors: Their Regulation of Epithelial Transporters and Involvement in Human Diseases Transporter-pdz Adaptor Interactions -2 , 2022 .

[18]  A. McLachlan,et al.  Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion–Transporting Polypeptides , 2012, Clinical pharmacology and therapeutics.

[19]  J. Boyer,et al.  Membrane Trafficking of the Human Organic Anion-Transporting Polypeptide C (hOATPC) , 2008, Pharmaceutical Research.

[20]  Maria J Perez,et al.  Further Characterization of the Electrogenicity and pH Sensitivity of the Human Organic Anion-Transporting Polypeptides OATP1B1 and OATP1B3 , 2011, Molecular Pharmacology.

[21]  A. Aguzzi,et al.  Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. , 2000, The Journal of pharmacology and experimental therapeutics.

[22]  G. Kullak-Ublick,et al.  The role of FXR in disorders of bile acid homeostasis. , 2008, Physiology.

[23]  A. Wolkoff,et al.  Oatp1a1 Requires PDZK1 to Traffic to the Plasma Membrane by Selective Recruitment of Microtubule-Based Motor Proteins , 2014, Drug Metabolism and Disposition.

[24]  T. Abe,et al.  Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates , 2002 .

[25]  P. Meier,et al.  Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. , 1995, Gastroenterology.

[26]  Vincent Laudet,et al.  Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.

[27]  P. Meier,et al.  The superfamily of organic anion transporting polypeptides. , 2003, Biochimica et biophysica acta.

[28]  R. Kim,et al.  Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1 , 2010, Hepatology.

[29]  A. Wolkoff,et al.  Topological assessment of oatp1a1: a 12-transmembrane domain integral membrane protein with three N-linked carbohydrate chains. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[30]  A. Wolkoff,et al.  Organic Anion Transporting Polypeptide Mediates Organic Anion/HCO3 − Exchange* , 1997, The Journal of Biological Chemistry.

[31]  B. Timmermann,et al.  Interactions of Green Tea Catechins with Organic Anion-Transporting Polypeptides , 2009, Drug Metabolism and Disposition.

[32]  J. Nezu,et al.  Involvement of Human Organic Anion Transporting Polypeptide OATP-B (SLC21A9) in pH-Dependent Transport across Intestinal Apical Membrane , 2003, Journal of Pharmacology and Experimental Therapeutics.

[33]  H. Kusuhara,et al.  Epigenetic Regulation of Organic Anion Transporting Polypeptide 1B3 in Cancer Cell Lines , 2013, Pharmaceutical Research.

[34]  C. Funk,et al.  Substrate-Dependent Drug-Drug Interactions between Gemfibrozil, Fluvastatin and Other Organic Anion-Transporting Peptide (OATP) Substrates on OATP1B1, OATP2B1, and OATP1B3 , 2007, Drug Metabolism and Disposition.

[35]  H. Iro,et al.  Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms. , 2013, The American journal of pathology.

[36]  P. Meier,et al.  Pharmacogenetics of drug transporters in the enterohepatic circulation. , 2011, Pharmacogenomics.

[37]  B. Hagenbuch,et al.  Several Conserved Positively Charged Amino Acids in OATP1B1 are Involved in Binding or Translocation of Different Substrates , 2010, The Journal of Membrane Biology.

[38]  Bruno Stieger,et al.  The SLCO (former SLC21) superfamily of transporters. , 2013, Molecular aspects of medicine.

[39]  P. Neuvonen,et al.  Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake , 2011, Pharmacological Reviews.

[40]  H. Schiöth,et al.  Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters. , 2011, Gene.

[41]  B. Scharschmidt,et al.  Hepatic organic anion uptake in the rat. , 1975, The Journal of clinical investigation.

[42]  P. Meier,et al.  Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Nakanishi,et al.  Functional pleiotropy of organic anion transporting polypeptide OATP2B1 due to multiple binding sites. , 2012, Drug metabolism and pharmacokinetics.

[44]  Curtis D. Klaassen,et al.  Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation , 2010, Pharmacological Reviews.

[45]  U. John,et al.  Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. , 2010, Gastroenterology.

[46]  N. Cherrington,et al.  Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions , 2012, Expert opinion on drug metabolism & toxicology.

[47]  G. Groothuis,et al.  Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.

[48]  B. Stieger,et al.  Physiological and Biochemical Basis of Clinical Liver Function Tests: A Review , 2013, Annals of surgery.

[49]  Maria J Perez,et al.  OATP8/1B3-mediated Cotransport of Bile Acids and Glutathione , 2006, Journal of Biological Chemistry.

[50]  H. Glaeser,et al.  Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3 , 2010, British journal of pharmacology.

[51]  H. Kusuhara,et al.  Analysis of DNA Methylation and Histone Modification Profiles of Liver-Specific Transporters , 2009, Molecular Pharmacology.

[52]  H. Yamaguchi,et al.  Rapid stimulating effect of the antiarrhythmic agent amiodarone on absorption of organic anion compounds. , 2013, Drug metabolism and pharmacokinetics.

[53]  K. Brouwer,et al.  In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development , 2013, Clinical pharmacology and therapeutics.

[54]  J. König.  Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms. , 2011, Handbook of experimental pharmacology.

[55]  B. Stieger,et al.  Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis , 2011, Expert opinion on drug metabolism & toxicology.

[56]  P. Meier,et al.  Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver , 2001 .

[57]  N. Ballatori,et al.  Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[58]  M. Niemi.  Transporter Pharmacogenetics and Statin Toxicity , 2010, Clinical pharmacology and therapeutics.

[59]  Nan Li,et al.  Conserved Tryptophan Residues within Putative Transmembrane Domain 6 Affect Transport Function of Organic Anion Transporting Polypeptide 1B1 , 2013, Molecular Pharmacology.

[60]  T. Nakanishi,et al.  Species Difference in the Effect of Grapefruit Juice on Intestinal Absorption of Talinolol between Human and Rat , 2010, Journal of Pharmacology and Experimental Therapeutics.

[61]  A. Minihane,et al.  Green tea (Camellia sinensis) catechins and vascular function , 2009, British Journal of Nutrition.

[62]  M. Trauner,et al.  Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. , 2007, Biochimica et biophysica acta.

[63]  H. Wirz.  Kidney, water and electrolyte metabolism. , 1961, Annual review of physiology.

[64]  P. Dawson,et al.  Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.

[65]  R. Benya,et al.  Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation , 2011, Clinical Epigenetics.

[66]  R. Kim,et al.  Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. , 2009, Molecular pharmaceutics.

[67]  K. Brouwer,et al.  Interaction of Silymarin Flavonolignans with Organic Anion-Transporting Polypeptides , 2013, Drug Metabolism and Disposition.

[68]  R. Kim,et al.  Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity. , 2012, Molecular pharmaceutics.

[69]  G. Kullak-Ublick,et al.  Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. , 2008, Pharmacogenomics.

[70]  J. Glavy,et al.  Down-regulation by Extracellular ATP of Rat Hepatocyte Organic Anion Transport Is Mediated by Serine Phosphorylation of Oatp1* , 2000, The Journal of Biological Chemistry.

[71]  N. Kaplowitz,et al.  The thiol sensitivity of glutathione transport in sidedness-sorted basolateral liver plasma membrane and in Oatp1-expressing HeLa cell membrane. , 2002, Molecular pharmacology.

[72]  P. Meier,et al.  Hepatic Transport of Bile Salts , 2000, Seminars in liver disease.

[73]  P. Meier,et al.  Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain , 1998, FEBS letters.

[74]  Donghak Kim,et al.  Role of hypoxia inducible factor-1α in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer. , 2013, Biochemical pharmacology.

[75]  Adam S. Hayward,et al.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.

[76]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[77]  L Zhang,et al.  Transporter Studies in Drug Development: Experience to Date and Follow‐Up on Decision Trees From the International Transporter Consortium , 2013, Clinical pharmacology and therapeutics.

[78]  Yuichi Sugiyama,et al.  Impact of microdosing clinical study -- why necessary and how useful? , 2011, Advanced drug delivery reviews.

[79]  Katrin Wlcek,et al.  Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin , 2013, Drug Metabolism and Disposition.

[80]  N. Ballatori,et al.  Identification of Glutathione as a Driving Force and Leukotriene C4 as a Substrate for oatp1, the Hepatic Sinusoidal Organic Solute Transporter* , 1998, The Journal of Biological Chemistry.

[81]  R. Angeletti,et al.  Interaction with PDZK1 Is Required for Expression of Organic Anion Transporting Protein 1A1 on the Hepatocyte Surface* , 2005, Journal of Biological Chemistry.

[82]  M. Niemi,et al.  Impact of OATP transporters on pharmacokinetics , 2009, British journal of pharmacology.

[83]  R. Kim,et al.  Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice , 2007, Clinical pharmacology and therapeutics.

[84]  H. Schrem,et al.  Liver-Enriched Transcription Factors in Liver Function and Development. Part I: The Hepatocyte Nuclear Factor Network and Liver-Specific Gene Expression , 2002, Pharmacological Reviews.

[85]  O. Langer,et al.  PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo. , 2011, Current drug metabolism.

[86]  E. Petzinger,et al.  Common properties of hepatocellular uptake of cholate, iodipamide and antamanide, as distinct from the uptake of bromosulfophthalein , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

[87]  A. Wolkoff,et al.  Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter. , 1991, The Journal of clinical investigation.

[88]  C. Gui,et al.  Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[89]  H. Kusuhara,et al.  DNA Methylation and Histone Modification Profiles of Mouse Organic Anion Transporting Polypeptides , 2013, Drug Metabolism and Disposition.

[90]  M. Romero,et al.  Substrate- and pH-Specific Antifolate Transport Mediated by Organic Anion-Transporting Polypeptide 2B1 (OATP2B1-SLCO2B1) , 2012, Molecular Pharmacology.

[91]  H. Glaeser,et al.  Inhibition of hepatic uptake transporters by flavonoids. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[92]  N. Ballatori,et al.  Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. , 2000, Molecular pharmacology.

[93]  D. Keppler,et al.  Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide* , 2000, The Journal of Biological Chemistry.

[94]  M. Fraunholz,et al.  Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization* , 2010, The Journal of Biological Chemistry.

[95]  M. Morris,et al.  FLAVONOIDS AS A NOVEL CLASS OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP1B1 (OATP-C) MODULATORS , 2005, Drug Metabolism and Disposition.

[96]  J. Nezu,et al.  Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human , 2004, Journal of Pharmacology and Experimental Therapeutics.

[97]  E. Wright,et al.  Expression cloning and cDNA sequencing of the Na+/glucose co-transporter , 1987, Nature.

[98]  Y. Sugiyama,et al.  Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver , 2013, Clinical pharmacology and therapeutics.

[99]  C. Gui,et al.  Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport. , 2008, Biochemistry.

[100]  K. Maeda,et al.  The Eighth and Ninth Transmembrane Domains in Organic Anion Transporting Polypeptide 1B1 Affect the Transport Kinetics of Estrone-3-Sulfate and Estradiol-17β-D-glucuronide , 2009, Journal of Pharmacology and Experimental Therapeutics.

[101]  Yuichi Sugiyama,et al.  In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. , 2009, Drug metabolism and pharmacokinetics.

[102]  N. Nakamichi,et al.  PDZK1 regulates organic anion transporting polypeptide Oatp1a in mouse small intestine. , 2010, Drug metabolism and pharmacokinetics.

[103]  T. Tai,et al.  Polyphenols: Benefits to the Cardiovascular System in Health and in Aging , 2013, Nutrients.

[104]  H. Glaeser,et al.  Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. , 2010, Biochemical pharmacology.

[105]  R. Angeletti,et al.  Rat organic anion transporting protein 1A1 (Oatp1a1): purification and phosphopeptide assignment. , 2006, Biochemistry.

[106]  S. Shankar,et al.  Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. , 2011, Biochemical pharmacology.

[107]  Martín J Lavecchia,et al.  Computational chemical analysis of unconjugated bilirubin anions and insights into pKa values clarification. , 2013, The Journal of chemical physics.

[108]  D. Meijer,et al.  Drug uptake systems in liver and kidney. , 2003, Current drug metabolism.

[109]  Sang Chung,et al.  New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process , 2008, Journal of clinical pharmacology.

[110]  D. B. Duignan,et al.  pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1. , 2011, Molecular pharmaceutics.

[111]  D. Hua,et al.  Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives. , 2013, Journal of natural products.

[112]  H. Fasold,et al.  Further characterization of membrane proteins involved in the transport of organic anions in hepatocytes. Comparison of two different affinity labels: 4,4'-diisothiocyano-1,2-diphenylethane-2,2'-disulfonic acid and brominated taurodehydrocholic acid. , 1984, Biochimica et biophysica acta.

[113]  Katrin Wlcek,et al.  Organic anion transporting polypeptides (OATPs): regulation of expression and function. , 2011, Current drug metabolism.

[114]  Peter J. Meier,et al.  Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.

[115]  P. Meier,et al.  Expression cloning of a rat liver Na(+)-independent organic anion transporter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[116]  L Landmann,et al.  Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. , 2001, Gastroenterology.

[117]  G. Kullak-Ublick,et al.  The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor , 2012, Molecular Pharmacology.

[118]  G. Groothuis,et al.  Analysis of bile acid‐induced regulation of FXR target genes in human liver slices , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[119]  J. Boyer,et al.  Hepatic transport systems regulating pHi, cell volume, and bile secretion. , 1992, Annual review of physiology.

[120]  B. Hagenbuch,et al.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies , 2012, British journal of pharmacology.

[121]  L. Gresh,et al.  Characterization of the Human OATP-C (SLC21A6) Gene Promoter and Regulation of Liver-specific OATP Genes by Hepatocyte Nuclear Factor 1α* , 2001, The Journal of Biological Chemistry.

[122]  R. Kim,et al.  Polymorphisms in OATP-C , 2001, The Journal of Biological Chemistry.

[123]  R. Kim,et al.  Impact of genetic variation in OATP transporters to drug disposition and response. , 2013, Drug metabolism and pharmacokinetics.

[124]  Bruno Hagenbuch,et al.  The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. , 2012, Annual review of pharmacology and toxicology.

[125]  P. Meier,et al.  Functional Analysis of the Extracellular Cysteine Residues in the Human Organic Anion Transporting Polypeptide, OATP2B1 , 2006, Molecular Pharmacology.

[126]  Shiew-Mei Huang,et al.  Scientific perspectives on drug transporters and their role in drug interactions. , 2006, Molecular pharmaceutics.

[127]  P. Meier,et al.  Multispecific amphipathic substrate transport by an organic anion transporter of human liver. , 1996, Journal of hepatology.

[128]  Y. Kato,et al.  Screening of the Interaction Between Xenobiotic Transporters and PDZ Proteins , 2004, Pharmaceutical Research.

[129]  R. Kim,et al.  Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans , 2007, Clinical pharmacology and therapeutics.

[130]  J. Ostrow,et al.  Review: Bilirubin pKa studies; new models and theories indicate high pKa values in water, dimethylformamide and DMSO , 2010, BMC Biochemistry.

[131]  Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments. , 2011, Current drug metabolism.

[132]  Kazuya Maeda,et al.  Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. , 2013, Biopharmaceutics & drug disposition.

[133]  T. Nakanishi,et al.  Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs. , 2012, Drug metabolism and pharmacokinetics.

[134]  C. Gui,et al.  Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1 , 2009, Protein science : a publication of the Protein Society.

[135]  T. Abe,et al.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. , 2001, Gastroenterology.

[136]  C. Gui,et al.  Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. , 2008, European journal of pharmacology.

[137]  J. Marin,et al.  Sensitivity of bile acid transport by organic anion-transporting polypeptides to intracellular pH. , 2003, Biochimica et biophysica acta.

[138]  D. Keppler,et al.  Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6* , 2001, The Journal of Biological Chemistry.

[139]  S. Spencer,et al.  Contribution of the OATP1B Subfamily to Cancer Biology and Treatment , 2012, Clinical pharmacology and therapeutics.

[140]  K. Ziegler,et al.  The transport of bile acids in liver cells. , 1988, Biochimica et biophysica acta.

[141]  H. Glaeser,et al.  Functional and Structural Relevance of Conserved Positively Charged Lysine Residues in Organic Anion Transporting Polypeptide 1B3 , 2011, Molecular Pharmacology.

[142]  Bruno Stieger,et al.  Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. , 2009, American journal of physiology. Cell physiology.

[143]  P. Meier,et al.  Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. , 1996, The Biochemical journal.

[144]  H. Kroemer,et al.  Modification of OATP2B1-Mediated Transport by Steroid Hormones , 2006, Molecular Pharmacology.

[145]  Mei Hong,et al.  N-glycosylation Dictates Proper Processing of Organic Anion Transporting Polypeptide 1B1 , 2012, PloS one.

[146]  C. Kao,et al.  Shared and separate pathways for biliary excretion of bilirubin and BSP in rats. , 1973, The American journal of physiology.

[147]  P. Ratcliffe,et al.  Pan-genomic binding of hypoxia-inducible transcription factors , 2013, Biological chemistry.

[148]  Fanfan Zhou,et al.  Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2 , 2011, British journal of pharmacology.

[149]  D. Keppler,et al.  A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[150]  M. Frimmer.  Organotropism by carrier-mediated transport , 1982 .

[151]  Crispin J. Miller,et al.  An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. , 2013, European journal of cancer.

[152]  G. Folkers,et al.  Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. , 2002, Molecular endocrinology.

[153]  C. Klaassen,et al.  Protein kinase C suppresses rat organic anion transporting polypeptide 1- and 2-mediated uptake. , 2001, The Journal of pharmacology and experimental therapeutics.

[154]  Shiew-Mei Huang,et al.  Transporter‐Mediated Drug–Drug Interactions , 2011, Clinical pharmacology and therapeutics.

[155]  Hugh A Barton,et al.  The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[156]  Yongxue Sun,et al.  Identification of Multiple Binding Sites for Substrate Transport in Bovine Organic Anion Transporting Polypeptide 1a2 , 2013, Drug Metabolism and Disposition.

[157]  D. Keppler,et al.  Molecular characterization and inhibition of amanitin uptake into human hepatocytes. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[158]  T. Abe,et al.  Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates. , 2002, Drug Metabolism And Disposition.

[159]  V. Sasseville,et al.  A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2) , 1999, The Journal of Biological Chemistry.

[160]  K. Mizuguchi,et al.  Organic Anion Transporting Polypeptides of the OATP/SLCO Superfamily: Identification of New Members in Nonmammalian Species, Comparative Modeling and a Potential Transport Mode , 2006, The Journal of Membrane Biology.

[161]  J. Nezu,et al.  Functional Characterization of Human Organic Anion Transporting Polypeptide B (OATP-B) in Comparison with Liver-Specific OATP-C , 2001, Pharmaceutical Research.

[162]  H. Yawo,et al.  Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1* , 1999, The Journal of Biological Chemistry.

[163]  L Zhang,et al.  A regulatory viewpoint on transporter-based drug interactions. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[164]  P. Meier,et al.  Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.

[165]  Tianyu Liu,et al.  Organic anion-transporting polypeptides: a novel approach for cancer therapy , 2014, Journal of drug targeting.